Epkinly (epcoritamab) is a subcutaneously delivered CD3×CD20 BiTE that secured FDA accelerated approval in 2023 for r/r DLBCL.

Bristol Myers Squibb ( NYSE: BMY) said that an analysis of data from a phase 2 cohort of patients with marginal zone lymphoma showed that treatment with Breyanzi (lisocabtagene maraleucel; liso-cel) ...

The combo therapy demonstrated an ORR of 87%, with a complete response rate of 65% and a partial response rate of 23%.

Analysts at Truist Securities called J&J’s CAR-T readout “compelling,” noting that the efficacy figures could position the ...

Johnson & Johnson’s dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma: Milan Monday, June 16, 2025, 14:00 Hrs [IST] Johnson & Johnson an ...

The small details that add up to shocking truths and suspenseful music that keeps us on our toes? We’re here for it. But the truth is, not all true crime podcasts are created equal. The narration is ...

Hailey Mack of Ocean View and Avery Eileen Martinenza of Newark were crowned Miss Delaware 2025 and Miss Delaware’s Teen 2025.

Josie Patterson wrote a magical story that was turned into a musical performance through the nonprofit Sing Me a Story ...

Leukaemia and lymphoma are among the most common forms of blood cancer and are often difficult to detect early and emotionally overwhelming for patients and families. However, they are no longer a ...

Owner Katie Bridge first became concerned about her S. Bernard Hercules' health when he began to suffer with an upset stomach ...

"We’re determined to make the most of every moment, keep positive and show people that there is life after cancer" ...

Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.